The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: A large study from a single institution
(Cancer Research UK) Upcoming publication from the British Journal of Cancer, investigating HER2 expression as a predictor of recurrence and development in patients with DCIS. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2019 Category: Cancer & Oncology Source Type: news
ASBrS: Less-invasive mastectomy safe for more women
A type of mastectomy that leaves the surface of the breast intact is a safe...Read more on AuntMinnie.comRelated Reading:
Contrast mammo equals MRI for measuring tumor size
Racial factors affect time to breast cancer treatment
Breast MRI helps guide DCIS treatment
Women still need breast imaging after mastectomy
Breast cancer follow-up imaging varies widely (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 3, 2019 Category: Radiology Source Type: news
Six Prognostic Factors ID ’ d for Invasive Disease After DCIS
Six significant factors include African - American race, premenopausal status, detection by palpation (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 25, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news
Six Factors Tied to DCIS Returning as Breast Cancer Six Factors Tied to DCIS Returning as Breast Cancer
A group of six factors are associated with ductal carcinoma in situ returning as invasive breast cancer after treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Six Prognostic Factors ID'd for Invasive Disease After DCIS
THURSDAY, April 25, 2019 -- In a review published online April 25 in Cancer Epidemiology, Biomarkers& Prevention, six prognostic factors are identified that may predict invasive disease after a diagnosis of ductal carcinoma in situ... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 25, 2019 Category: Pharmaceuticals Source Type: news
Six factors may predict invasive breast cancer recurrence after DCIS diagnosis
(American Association for Cancer Research) Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to data from a meta-analysis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 25, 2019 Category: Cancer & Oncology Source Type: news
Smart Biopsy Device Could Diagnose Breast Cancer Using Miniature Radiofrequency Sensors
Normally, when a physician notices a suspicious mass or lesion on a mammogram, he or she will request an ultrasound to explore it further. Based on those results, a biopsy may be performed to determine whether the mass is cancerous. “Unfortunately, right now, in some cases, physicians either overdiagnose or underdiagnose based on that biopsy, because with ultrasound they can only see so much,†said Lori Chmura, CEO of Dune Medical Devices. “The doctor is essentially going in blindly, trying to see what looks like the most suspicious area, and they’re t...
Source: MDDI - March 12, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Business Source Type: news
Stereotactic radiation extends long-term survival
for some patients with stage...Read more on AuntMinnie.comRelated Reading:
ASTRO: SABR is effective for oligometastatic cancers
ASTRO: Weekly breast radiation therapy is safe
ASTRO: AI's rad therapy future is in predicting outcomes
Is radiation therapy warranted for DCIS postlumpectomy?
ASTRO: Short radiation course safe for breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 31, 2019 Category: Radiology Source Type: news
Breast MRI effective as adjunct to DBT in high-risk women
Breast MRI is an effective adjunct screening technology for women at high risk...Read more on AuntMinnie.comRelated Reading:
Breast MRI helps guide DCIS treatment
Tissue enhancement on breast MRI informs cancer risk
Breast MRI works for evaluating equivocal DBT findings
High-risk women benefit from twice-yearly breast MRI
Can Tetris inspire AI for MRI breast cancer detection? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 25, 2019 Category: Radiology Source Type: news
Breast MRI helps guide DCIS treatment
Breast MRI -- along with tests that characterize breast cancer genes -- can...Read more on AuntMinnie.comRelated Reading:
Breast MRI works for evaluating equivocal DBT findings
High-risk women benefit from twice-yearly breast MRI
Breast MRI underutilized in high-risk women
Breast MRI improves PPV for BI-RADS category 4B lesions
Multiparametric MRI shines for suspected breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 21, 2019 Category: Radiology Source Type: news
Using Radiation Therapy to Reduce Recurrence in DCIS
Cancer Network spoke with Dr. Carmen Bergom about advancements in the treatment of DCIS and the importance of using local recurrence patterns to help guide future research. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Carmen Bergom, MD, PhD Source Type: news
Tissue enhancement on breast MRI informs cancer risk
Elevated levels of background parenchymal enhancement on breast MRI increase...Read more on AuntMinnie.comRelated Reading:
Breast MRI effective for postpartum breast cancer
The 'ins and outs' of imaging dense breasts
Normal tissue enhancement on breast MR predicts cancer risk
Breast MRI CAD doesn't improve accuracy due to poor DCIS detection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 14, 2019 Category: Radiology Source Type: news
Go Low With Tamoxifen for DCIS Go Low With Tamoxifen for DCIS
In a potentially practice-changing result, use of a 5-mg daily dose of tamoxifen for patients with ductal carcinoma in situ (DCIS) prevented new and recurrent breast cancer events in comparison with placebo.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Low-dose tamoxifen reduced recurrence and new disease for patients with DCIS, LCIS, and ADH
(American Association for Cancer Research) Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease recurrence and new disease for women who had been treated with surgery following a diagnosis of breast intraepithelial neoplasia compared with placebo, and it did not cause more serious adverse events, according to data from the randomized, phase III TAM-01 clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news
Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with 'good risk'
(American Society for Radiation Oncology) A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report. These 12-year follow-up data from the only prospective, randomized trial to compare recurrence outcomes after treatment for low-risk ductal carcinoma in situ (DCIS) were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2018 Category: Cancer & Oncology Source Type: news
ASTRO: SABR is effective for oligometastatic cancers
Stereotactic ablative radiotherapy (SABR) can greatly increase how long oligometastatic...Read more on AuntMinnie.comRelated Reading:
ASTRO: Weekly breast radiation therapy is safe
ASTRO: AI's rad therapy future is in predicting outcomes
Study gives all-clear for skin cream during radiation therapy
PET/CT predicts success of rad therapy for spinal mets
Is radiation therapy warranted for DCIS postlumpectomy? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 23, 2018 Category: Radiology Source Type: news
Radiation Therapy Cuts Recurrence in'Good Risk' DCIS Radiation Therapy Cuts Recurrence in'Good Risk' DCIS
Whole-breast radiation halved the risk for recurrence in low-risk ductal carcinoma in situ (DCIS), but treatment after surgery needs to part of a physician-patient discussion.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
RT Add-On Boosts Outcomes in'Low-Risk' DCIS Breast Ca
(MedPage Today) -- Highest benefit seen in patients who also used tamoxifen (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 22, 2018 Category: Hematology Source Type: news
ASTRO: Radiation therapy slashes breast cancer recurrence
Whole-breast radiation therapy can significantly lower the risk of recurrent...Read more on AuntMinnie.comRelated Reading:
Can dedicated breast PET identify suspicious lesions?
Women still need breast imaging after mastectomy
Is radiation therapy warranted for DCIS postlumpectomy?
Microbubbles improve breast cancer radiation therapy
ASTRO: Short radiation course safe for breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 21, 2018 Category: Radiology Source Type: news
ASTRO: Weekly breast radiation therapy is safe
A larger, weekly dose of radiation therapy has side effects that are comparable...Read more on AuntMinnie.comRelated Reading:
Can dedicated breast PET identify suspicious lesions?
Women still need breast imaging after mastectomy
Is radiation therapy warranted for DCIS postlumpectomy?
Microbubbles improve breast cancer radiation therapy
ASTRO: Short radiation course safe for breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 21, 2018 Category: Radiology Source Type: news
Women still need breast imaging after mastectomy
Although women may be increasingly choosing mastectomy as a breast cancer treatment,...Read more on AuntMinnie.comRelated Reading:
Fewer high-risk women get mammography after USPSTF change
Is radiation therapy warranted for DCIS postlumpectomy?
Breast cancer follow-up imaging varies widely
Biopsy rate is low after breast cancer
What's the best way to follow up breast cancer survivors? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 9, 2018 Category: Radiology Source Type: news
Mastectomy Not the Only Option in Extensive DCIS
(MedPage Today) -- Lumpectomy plus RT viable if risks, benefits are explained (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - September 28, 2018 Category: OBGYN Source Type: news
Lumpectomy + Radiation May Cut Breast Cancer Mortality in DCIS
Lumpectomy, radiotherapy tied to reduction in breast cancer mortality versus lumpectomy, mastectomy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 20, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Surgery, Journal, Source Type: news
Lumpectomy & #43; Radiation May Cut Breast Cancer Mortality in DCIS
MONDAY, Aug. 20, 2018 -- Treatment with lumpectomy and radiotherapy is associated with a reduction in breast cancer mortality versus lumpectomy or mastectomy alone among patients with ductal carcinoma in situ (DCIS), according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 20, 2018 Category: Pharmaceuticals Source Type: news
Is radiation therapy warranted for DCIS postlumpectomy?
Researchers have found that radiation therapy after lumpectomy in women with...Read more on AuntMinnie.comRelated Reading:
Microbubbles improve breast cancer radiation therapy
ASTRO: Short radiation course safe for breast cancer
LED device could predict skin damage from breast RT
Robotic IMRT-APBI works well for breast cancer patients
SABCS: Study links APBI to higher complication rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2018 Category: Radiology Source Type: news
Lumpectomy Plus RT Tied to Lower Mortality in DCIS Lumpectomy Plus RT Tied to Lower Mortality in DCIS
Lumpectomy plus radiation is associated with a small but statistically significant reduced risk for breast cancer-related death compared to the other major options for ductal carcinoma in situ (DCIS).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Association of radiation therapy plus lumpectomy in reduced risk of dying in women with DCIS
(JAMA Network) Lumpectomy plus radiation was associated with a small clinical benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone in women with ductal carcinoma in situ (DCIS), a noninvasive early form of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 10, 2018 Category: Cancer & Oncology Source Type: news
ASBrS: Regular mammo screening = less-invasive treatment
Regular breast cancer screening, particularly in younger women, translates...Read more on AuntMinnie.comRelated Reading:
ASBrS: No, we're not overtreating DCIS
ASBrS: 50% of women under 45 at elevated breast cancer risk
ASBrS: For node-positive breast cancer, radiotherapy is best
ASBrS: Radiotherapy after mastectomy may not be beneficial
ASBrS: RF ablation shows promise; thermography not so much (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 7, 2018 Category: Radiology Source Type: news
Does double reading improve breast cancer screening?
Conclusions? 1) My conclusion is that this proves that double reading adds nothing important to screening - particularly if women are getting yearly mammograms. This should be the stake in the heart of the double reading vampire. Given the criticism of mammography - that it doesn't save many, or any lives, this extra tenth of a percent of diagnosis is even more questionable. Nah, not just questionable, I'd say it is so low that there are probably, within error bars, no lives saved. Do they say this. No: "Detecting these extra cancers may be associated with detecting important patho...
Source: AuntMinnie.com Headlines - April 19, 2018 Category: Radiology Source Type: news
Women With DCIS Who Are at Low Risk for Recurrence Identified Women With DCIS Who Are at Low Risk for Recurrence Identified
Women with ductal carcinoma in situ (DCIS) who are at low risk for disease recurrence after conservative breast surgery and radiotherapy, and whose treatment could be reduced, have been identified.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Managing Ductal Carcinoma In Situ in the Era of Genomic Profiling
At the 2018 Miami Breast Cancer Conference, Dr. Patrick Borgen presented information related to gene expression profiling as a tool for managing DCIS. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2018 Category: Cancer & Oncology Authors: Patrick I. Borgen, MD Tags: Breast Cancer Conference Report Conferences/MBCC Source Type: news
Women with DCIS at lowest risk of recurrence if they are post-menopausal or ER+
(ECCO-the European CanCer Organisation) Patients with an early form of breast cancer are less likely to suffer a recurrence if they are post-menopausal or if their tumour is oestrogen receptor positive, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news
Cancer: Breast radiation therapy isn't so bad
Women with breast cancer who undergo radiation therapy may have fears about...Read more on AuntMinnie.comRelated Reading:
Biopsy rate is low after breast cancer
ASTRO: Breast radiation 'less scary' than expected
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy
Accelerated RT with boost works well for breast cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 1, 2018 Category: Radiology Source Type: news
High Detection Rates of High - Grade DCIS Persist
Low - , intermediate - grade DCIS less frequently ID'd in subsequent screening rounds vs. prevalence round (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 7, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Radiology, Journal, Source Type: news
Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial
This research article has led to a Practice Changing Update in DynaMed Plus. It concludes that radioactive seed localization may have similar positive margin but higher successful placement rates compared to wire localization in women having breast-conserving surgery for nonpalpable invasive breast cancer or ductal carcinoma in situ (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 18, 2018 Category: Consumer Health News Source Type: news
' Cultural Change' in DCIS'Cultural Change' in DCIS
Some think it's time to change how we talk about DCIS and to consider de-escalation of therapy. Drs Kathy Miller and Shelley Hwang discuss these hot topics and the COMET study at SABCS 2017.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
New Analytical Tool May Determine How DCIS Invasion Occurs
A new analytical tool called topographic single-cell sequencing can reveal a direct genomic lineage between in situ and invasive tumor subpopulations, which may help decipher how and why some DCIS become invasive. (Source: CancerNetwork)
Source: CancerNetwork - January 16, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Breast Cancer News Source Type: news
New cancer model shows genomic link between early-stage and invasive breast cancer types
(University of Texas M. D. Anderson Cancer Center) A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer say researchers at The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 4, 2018 Category: Biology Source Type: news
Women not getting recommended breast radiation therapy
Almost 10% of women don't receive radiation therapy after breast conservation...Read more on AuntMinnie.comRelated Reading:
ASTRO: Breast radiation 'less scary' than expected
JCO releases new sentinel node biopsy guidelines
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2017 Category: Radiology Source Type: news
Sharing Mayo Clinic: Breast cancer patient finds answer in centralized care
Renee Hill had received opinions from other health care facilities but desperately wanted to have her medical care centralized and coordinated. "My gut was telling me Mayo was where I needed to go," she says.? When Renee Hill was diagnosed with breast cancer ? stage 3 invasive ductal carcinoma ? on her birthday in July [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 22, 2017 Category: Databases & Libraries Source Type: news
Rare Neuroendocrine Breast Cancer Not So Unusual Rare Neuroendocrine Breast Cancer Not So Unusual
Neuroendocrine breast cancer can be indistinguishable from high-grade ductal carcinoma, although treatment is different, and can be missed unless stained specifically for neuroendocrine markers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 7, 2017 Category: Consumer Health News Tags: Pathology & Lab Medicine News Source Type: news
Local DCIS Recurrence After Skipping Adjuvant Radiation Local DCIS Recurrence After Skipping Adjuvant Radiation
Omitting radiation after lumpectomy for pure ductal carcinoma in situ (DCIS) does not improve the chance of breast preservation in case of local recurrence, researchers from Canada have observed.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 6, 2017 Category: Surgery Tags: Hematology-Oncology News Source Type: news
COUNTERPOINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?
To universally recommend breast irradiation for all women after excision of DCIS lesions ignores information now available to us that can spare the majority of women with DCIS the downsides of RT, but be applied in the treatment of DCIS patients at greater risk for invasive disease. (Source: CancerNetwork)
Source: CancerNetwork - August 15, 2017 Category: Cancer & Oncology Authors: William C. Wood, MD Tags: Breast Cancer Oncology Journal Source Type: news
POINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?
At this time RT following BCS remains the standard of care for most patients. Current tools, including prognostic scores and tumor genetics, have failed to identify a cohort for whom RT confers no benefit with respect to invasive recurrences. (Source: CancerNetwork)
Source: CancerNetwork - August 15, 2017 Category: Cancer & Oncology Authors: Camille Berriochoa, MD Carisa Bohnak, BS Chirag Shah, MD Nicole Chahine, BS Tags: Breast Cancer Oncology Journal Source Type: news
Benefit of Radiotherapy After Breast Conservation in DCIS Benefit of Radiotherapy After Breast Conservation in DCIS
Can this molecular assay help determine who will benefit from radiotherapy after breast-conserving therapy for DCIS?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Don ’t Be Fooled by DCIS
A 46-year-old woman had a routine screening mammogram that showed new calcifications in the posterior left breast. A diagnostic mammogram showed several small punctate calcifications, and a 6-month interval follow-up was recommended. (Source: CancerNetwork)
Source: CancerNetwork - July 15, 2017 Category: Cancer & Oncology Authors: Colleen D. Murphy, MD Dulcy E. Wolverton, MD Rachel A. Rabinovitch, MD Regina J. Brown, MD Sharon Sams, MD, MPH Tae Chong, MD Virginia F. Borges, MD, MMSc Tags: Breast Cancer Case Studies Oncology Journal Source Type: news
Case: Traumatic Neuroma of the Breast After Mastectomy Case: Traumatic Neuroma of the Breast After Mastectomy
What was the etiology of this small mass found on screening mammogram in a woman with a history of invasive ductal carcinoma and modified radical mastectomy?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 3, 2017 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news
Photoacoustic imaging could guide breast cancer removal
A new technique based on photoacoustic imaging could help surgeons determine...Read more on AuntMinnie.comRelated Reading:
Contrast US helps assess breast cancer treatment response
Bilateral mastectomy not needed for DCIS
DBT reduces breast surgery re-excision rates
Supine MRI in the OR can improve breast surgery outcome
Lumpectomy with RT tops mastectomy for early-stage cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 17, 2017 Category: Radiology Source Type: news
' Unique' DCIS Study: Double Mastectomy Not Needed'Unique' DCIS Study: Double Mastectomy Not Needed
Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Triple-modality therapy foils rare breast cancer
Traditional triple-modality therapy for breast cancer also works for a rare...Read more on AuntMinnie.comRelated Reading:
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy
Accelerated RT with boost works well for breast cancer patients
Bras aid positioning for large-breasted women during RT
ASCO BSC: Long-term APBI outcomes are favorable (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 28, 2017 Category: Radiology Source Type: news
